Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2003
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP0873330B1 Diarylalkenylamine derivatives
05/14/2003EP0794788B1 Hepatic-directed compounds and reagents for preparation thereof
05/14/2003EP0749308B1 Film coated tablet of paracetamol and domperidone
05/14/2003CN1418217A Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof
05/14/2003CN1418216A Novel 2,3,4,5-tetrahydro-1H-[1,4] diazepino [1,7a]indole compound
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418207A Agents correcting gene expression regulatory error
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418188A Method for oxidizing thioether group into sulfoxide group
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418111A Novel Ligands and method for preparing same
05/14/2003CN1418110A Remedies for sjoegrens syndrome
05/14/2003CN1418103A Polysaccharidic esters of N-derivatives of glutamic acid
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1417326A Latent-energy regeneration cell
05/14/2003CN1416901A Compound oral prepn for treating pyloric spirobacterium infection
05/14/2003CN1416894A Secreted recombinant human interferon alpha-2a injection liquid
05/14/2003CN1416888A White peony and licorice extract and its prepn process
05/14/2003CN1416885A Andrographis gel as supplementary medicine for treating preiodontitis
05/14/2003CN1416874A Medicated pillow and its making process
05/14/2003CN1416872A Health wine for expelling wind, clearing away cold and removing dampness
05/14/2003CN1416871A Chinese medicine oral liquid for treating hepatitis and its prepn
05/14/2003CN1416870A Toothache treating Chinese medicine
05/14/2003CN1416867A Effective cure made of natural plant material for treating AlDS, hepatitis B, hepatitis C and cancer
05/14/2003CN1416865A Medicine prepn for treating halitosis
05/14/2003CN1416864A Lidan capsule for treating liver and gall bladder system diseases
05/14/2003CN1416862A Gandanqing capsule
05/14/2003CN1416860A Prepn process of life prolonging tablet
05/14/2003CN1416858A Medicine with enteron-cleaning effect and its prepn
05/14/2003CN1416848A Capsule for treating chronic hepatitis B and its prepn
05/14/2003CN1416845A Medicated wine for treating duodenal cancer
05/14/2003CN1416842A Liver protecting compound prepn and its prepn process
05/14/2003CN1416839A Prepn of xuelukang oral liquid
05/14/2003CN1416838A Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process
05/14/2003CN1416836A Turtle essence oral liquid
05/14/2003CN1416834A Medicine for treating dental diseases
05/14/2003CN1416818A Application of aloe polysaccharide in medicine for treating chronic gastroduodenal ulcer
05/14/2003CN1416803A Oral cleaning liquid
05/14/2003CN1108365C Health-care beer with kidney-nourishing and liver-protecting function and its brewing technology
05/14/2003CN1108290C Urea derivatives
05/14/2003CN1108167C Shuangtian oil
05/14/2003CN1108163C Women's tonic wine and its preparation method
05/14/2003CN1108162C Men's tonic wine and its preparation method
05/14/2003CN1108161C Yichun wine and its preparation method
05/14/2003CN1108160C Medicine for curing stomatocace and its preparation method
05/14/2003CN1108110C Composition comprising viscosity modulating polymer material and its use
05/13/2003US6564152 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists
05/13/2003US6562995 Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters are disclosed. The novel compounds have two carbonyl groups connected by a linking moiety having
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562836 Islet amyloid polypeptide (IAPP) is known to be capable of forming fibrils which are deposited in the pancreas of patients wtih type II diabetes
05/13/2003US6562834 Combination comprising camptothecin and a stilbene derivative for the treatment of cancer
05/13/2003US6562831 Inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562824 Dihydropyridine soft drugs, and related compositions and methods
05/13/2003US6562816 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562810 8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors
05/13/2003US6562808 Calcium channel antagonists effective in treating intestinal diseases caused by abnormal acceleration of the contraction of intestinal tracts such as irritable bowel syndrome, without significant cardiac effects
05/13/2003US6562795 Motilide compounds
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562381 (+)-Cycloolivil as antioxidant obtained from natural source namely stereospermum personatum
05/13/2003US6562380 Methods for treating or reducing prediposition to breast cancer, pre-menstrual syndrome or symptoms associated with menopause by administration of phyto-estrogen
05/13/2003US6562363 Bioadhesive compositions and methods for topical administration of active agents
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003CA2307048C Galenic preparation for prevention and treatment of hepatocarcinoma
05/13/2003CA2300679C Method of reducing intestinal gas, cramping and anorectal irritation
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037905A1 Silicon compounds
05/08/2003WO2003037901A1 Bridged bicycle (1,4) benzodiazepine vasopressin receptor antagonists
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037895A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037894A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037887A1 Therapeutic isoquinoline compounds
05/08/2003WO2003037876A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037873A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037870A1 Substituted 1h-quinolin-2-one compounds
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037360A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
05/08/2003WO2003037358A1 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
1 ... 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 ... 1258